Association of v-erbA with smad4 disrupts TGF-β signaling

Molecular Biology of the Cell

Volumn 20, Issue 5, 2009, Pages 1509-1519

  Erickson, Richard A ^a   Liu, Xuedong ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN V ERBA; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; AVIAN ERYTHROBLASTOSIS ONCOVIRUS; CELL GROWTH; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ERYTHROLEUKEMIA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BINDING SITES; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; ERYTHROBLASTS; HUMANS; MUTATION; ONCOGENE PROTEINS V-ERBA; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AVIAN ERYTHROBLASTOSIS VIRUS;

EID: 65249118863     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-08-0836     Document Type: Article

References (48)

1. Beug, H., Doederlein, G., Freudenstein, C., and Graf, T. (1982). Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythro- blastosis virus: a model system to study erythroid differentiation in vitro. J. Cell Physiol. Suppl. 1, 195-207.
2. Bonde, B. G., and Privalsky, M. L. (1990). Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus. J. Virol. 64, 1314-1320.
3. Chen, F., and Weinberg, R. A. (1995). Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc. Natl. Acad. Sci. USA 92, 1565-1569.
4. Ciana, P., Braliou, G. G., Demay, F. G., von Lindern, M., Barettino, D., Beug, H., and Stunnenberg, H. G. (1998). Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. Embo J. 17, 7382-7394.
5. Damm, K., and Evans, R. M. (1993). Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid- hormone receptor alpha. Proc. Natl. Acad. Sci. USA 90, 10668-10672.
6. Damm, K.,Thompson,C. C.,and Evans,R. M. (1989). Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339, 593-597.
7. Datto, M. B., Hu, P. P., Kowalik, T. F., Yingling, J., and Wang, X. F. (1997). The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17, 2030-2037.
8. DeLong, L. J., Bonamy, G. M., Fink, E. N., and Allison, L. A. (2004). Nuclear export of the oncoprotein v-ErbA is mediated by acquisition of a viral nuclear export sequence. J. Biol. Chem. 279, 15356-15367.
9. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. (1993). TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020.
10. Frykberg, L., Palmieri, S., Beug, H., Graf, T., Hayman, M. J., and Vennstrom, B. (1983). Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes. Cell 32, 227-238.
11. Gonin-Giraud, S., Bresson-Mazet, C., and Gandrillon, O. (2008). Involvement of the TGF-beta and mTOR/p70S6Kinase pathways in the transformation process induced by v-ErbA. Leuk Res. 32, 1878-1888.
12. Graf, T., and Beug, H. (1983). Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell 34, 7-9.
13. Grignani, F., et al. (1998). Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815-818.
14. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
15. Hayman, M. J., Royer-Pokora, B., and Graf, T. (1979). Defectiveness of avian erythroblastosis virus: synthesis of a 75K gag-related protein. Virology 92, 31-45.
16. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
17. Hua, X., Liu, X., Ansari, D. O., and Lodish, H. F. (1998). Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12, 3084-3095.
18. Hua, X., Miller, Z. A., Wu, G., Shi, Y., and Lodish, H. F. (1999). Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 96, 13130-13135.
19. Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., and Hirai, H. (1998). The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature 394, 92-96.
20. La, P., Morgan, T. A., Sykes, S. M., Mao, H., Schnepp, R. W., Petersen, C. D., and Hua, X. (2003). Fusion proteins of retinoid receptors antagonize TGF- beta-induced growth inhibition of lung epithelial cells. Oncogene 22, 198-210.
21. Lin, C. R., Chen, W. S., Kruiger, W., Stolarsky, L. S., Weber, W., Evans, R. M., Verma, I. M., Gill, G. N., and Rosenfeld, M. G. (1984). Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science 224, 843-848.
22. Lin, R. J., and Evans, R. M. (2000). Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol. Cell 5, 821-830.
23. Lindstrom,M. S., Jin,A.,Deisenroth,C., White Wolf,G.,and Zhang,Y. (2007). Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol. Cell. Biol. 27, 1056-1068.
24. Liu,X.,Sun,Y.,Constantinescu,S. N.,Karam,E.,Weinberg,R. A.,and Lodish, H. F. (1997). Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA. 94, 10669-10674.
25. Luo, K. (2004). Ski and SnoN: negative regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 14, 65-70.
26. Massague, J., Blain, S. W., and Lo, R. S. (2000). TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309.
27. Metz, T. (1994). Oncogenes and erythroid differentiation. Semin. Cancer Biol. 5, 125-135.
28. Miyajima, N., Kadowaki, Y., Fukushige, S., Shimizu, S., Semba, K., Yamanashi, Y., Matsubara, K., Toyoshima, K., and Yamamoto, T. (1988). Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res. 16, 11057-11074.
29. Myers, J. W., Jones, J. T., Meyer, T., and Ferrell, J. E., Jr. (2003). Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat. Biotechnol. 21, 324-328.
30. Naviaux, R. K., Costanzi, E., Haas, M., and Verma, I. M. (1996). The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705.
31. Pierreux, C. E., Nicolas, F. J., and Hill, C. S. (2000). Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol. Cell. Biol. 20, 9041-9054.
32. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, P. M., and Moses, H. L. (1990). TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777-785.
33. Piu, F., Jurdic, P., Brun, G., Samarut, J., and Castellazzi, M. (1993). Transforming growth factor beta 1-mediated growth inhibition in chick embryo fibroblasts: reversion by virally-expressed nuclear oncogenes. CR Acad. Sci. III 316, 772-779.
34. Privalsky, M. L., Boucher, P., Koning, A., and Judelson, C. (1988). Genetic dissection of functional domains within the avian erythroblastosis virus v- erbA oncogene. Mol. Cell. Biol. 8, 4510-4517.
35. Rietveld, L. E., Caldenhoven, E., and Stunnenberg, H. G. (2001). Avian erythro- leukemia: a model for corepressor function in cancer. Oncogene 20, 3100-3109.
36. Rietveld, L. E., Caldenhoven, E., and Stunnenberg, H. G. (2002). In vivo repression of an erythroid-specific gene by distinct corepressor complexes. EMBO J. 21, 1389-1397.
37. Sap, J., Munoz, A., Damm, K., Goldberg, Y., Ghysdael, J., Leutz, A., Beug, H., and Vennstrom, B. (1986). The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324, 635-640.
38. Schwarte-Waldhoff, I., Klein, S., Blass-Kampmann, S., Hintelmann, A., Eilert, C., Dreschers, S., Kalthoff, H., Hahn, S. A., and Schmiegel, W. (1999). DPC4/ SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18, 3152-3158.
39. Sun, P., Dong, P., Dai, K., Hannon, G. J., and Beach, D. (1998). p53-indepen- dent role of MDM2 in TGF-beta1 resistance. Science 282, 2270-2272.
40. Thormeyer, D., and Baniahmad, A. (1999). The v-erbA oncogene (review). Int. J. Mol. Med. 4, 351-358.
41. Vennstrom, B., and Bishop, J. M. (1982). Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythro- blastosis virus. Cell 28, 135-143.
42. Vennstrom, B., Fanshier, L., Moscovici, C., and Bishop, J. M. (1980). Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells. J. Virol. 36, 575-585.
43. Wakefield, L. M., and Roberts, A. B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
44. Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., and Evans, R. M. (1986). The c-erb-A gene encodes a thyroid hormone receptor. Nature 324, 641-646.
45. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massague, J. (1992). TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
46. Xiao, Z., Latek, R., and Lodish, H. F. (2003). An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcrip- tional activity. Oncogene 22, 1057-1069.
47. Xiao, Z., Liu, X., Henis, Y. I., and Lodish, H. F. (2000). A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc. Natl. Acad. Sci. USA 97, 7853-7858.
48. Zenke, M., Munoz, A., Sap, J., Vennstrom, B., and Beug, H. (1990). v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61, 1035-1049.